US Patent 10532056 Therapeutic compositions, combinations, and methods of use
Patent 10532056 was granted and assigned to Verastem on January, 2020 by the United States Patent and Trademark Office.
All edits
Edits on 19 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 11 Dec, 2023
Golden AI
Edits made to:
Article (+258 characters)
Article
Patent abstract
This invention relates to methods comprising administering a FAK inhibitor and an immunotherapeutic agent such as anti-PD-1 or anti-PD-L1; that are useful in the treatment of abnormal cell growth, such as cancer, in mammals, especially humans.
Edits on 22 Nov, 2023
Megan Gustafson
Megan Gustafson
Edits on 7 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
Patent Number
105320560
Date of Patent
January 14, 2020
0Patent Application Number
157389990
Date Filed
June 29, 2016
0Patent Citations Received
Patent Primary Examiner
Edits on 26 Mar, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 7 Dec, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
Patent Number
105320560
Date of Patent
January 14, 2020
0Patent Application Number
157389990
Date Filed
June 29, 2016
0Patent Primary Examiner
Edits on 31 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10532056 Therapeutic compositions, combinations, and methods of use
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10532056
Date of patent
January 14, 2020
Patent application number
15738999
Date Filed
June 29, 2016
Patent primary examiner
Find more entities like US Patent 10532056 Therapeutic compositions, combinations, and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.